TPG Gp A portfolio

Private equity or venture capitalIndividual

Portfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 14, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

TPG Gp A reported a $5.0 bn portfolio of 80 companies (82 positions, counting each share class separately) to the SEC as of the end of Q2 2026. Its largest positions are LFST, SPCX, JXN. During the quarter it opened Invitation Homes and Achieve Life Sciences and exited Box.

Stock portfolio

$5.0 bn

Companies

82 positions (by CUSIP)Top 10: 76%

Turnover

25%

Copying its 13F, 5 years

—

Not calculated: not counted as a concentrated manager

Sections with a free account

What it reported after the quarter end (Q2 2026)

The 13F shows the portfolio as of Jun 30, 2026. Since then TPG Gp A has filed these own trades with the SEC (Form 4, when it owns more than 10% of a company or holds a role in it) and stakes above 5% (13D and 13G). It is not everything it did: only what it must report before the next 13F.

SoldLifeStance Health GroupLFST$371M
Form 4 · 32,052,912 shares · trades from Aug 10 to Sep 11 · filed Sep 15, 2026 · filing (latest of 2) ↗
13D/AAllogene TherapeuticsALLO0 %
Stake reported in the company · event of Sep 28, 2026 · filed Sep 30, 2026 · filing ↗
13D/ATPGTPG58.3 % → 56.4 %
Stake reported in the company · event of Aug 14, 2026 · filed Aug 18, 2026 · filing ↗
13G/ACeriBellCBLL11.1 % → 7.8 %
Stake reported in the company · event of Jun 30, 2026 · filed Aug 14, 2026 · filing ↗
13G/ALifeStance Health GroupLFST29.3 % → 25.7 %
Stake reported in the company · event of Jun 30, 2026 · filed Aug 14, 2026 · filing ↗

What changed this quarter

44 positions with a change (8 new, 11 added to, 17 trimmed, 8 sold); also, 10 entered through an IPO, 5 exited through an acquisition or merger, 1 entered through a spin-off. 7 are listed here: those of 0.5 points of the portfolio or more (up to 12).

Newly listedSpace Exploration TechnologiesSPCX14.7% of the portfolio
Newly listedOdyssey TherapeuticsODTX1.4% of the portfolio
Newly listedDoorDash0.6% of the portfolio
Newly listedAvalyn PharmaAVLN0.5% of the portfolio

It started trading this quarter: it appears in a 13F for the first time. The filing does not say whether the manager already held it before the listing, so it is not counted as a purchase.

Life Time Group Holdings−56%fewer sharesReduced
13.1% → 6.4%
LifeStance Health Group−20%fewer sharesReduced
24.2% → 23.9%
Invitation Homes+2.5 ppof portfolioNew
— → 2.5%
Achieve Life Sciences+0.9 ppof portfolioNew
— → 0.9%
Hewlett Packard Enterprise C−57%fewer sharesReduced
1.0% → 0.6%
Boeing+0.5 ppof portfolioNew
— → 0.5%
Box−0.5 ppof portfolioSold out
0.7% → —

The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.

Top holdings

LifeStance Health GroupLFST23.9%
Space Exploration TechnologiesSPCX14.7%
Jackson FinancialJXN9.7%
Life Time Group HoldingsLTH6.4%
Sionna TherapeuticsSION5.7%
BETA TechnologiesBETA5.5%
Amneal PharmaceuticalsAMRX4.3%
Invitation HomesINVH2.5%
NGL Energy PartnersNGL1.8%
Bicara TherapeuticsBCAX1.8%
Bruker(preferred)1.6%
CeriBellCBLL1.5%
Bofa FIN(bond)1.4%
Odyssey TherapeuticsODTX1.4%
WEC Energy Group(bond)1.2%
Pg&e(bond)1.1%
Achieve Life SciencesACHV0.9%
Evergy(bond)0.8%
Novanta(preferred)0.8%
Nextera Energy(preferred)0.8%
Allogene TherapeuticsALLO0.8%
Quanex Building ProductsNX0.8%
DoorDash(bond)0.6%
Hewlett Packard Enterprise C(preferred)0.6%
Boeing(preferred)0.5%
EnviriNVRI0.5%
Avalyn PharmaAVLN0.5%
Pinnacle West Cap(bond)0.5%
Starwood Ppty Tr(bond)0.5%
Firstenergy(bond)0.4%
PPL(preferred)0.4%
TPG RE Finance TrustTRTX0.4%
Microchip Technology(preferred)0.4%
Akamai Technologies(bond)0.4%
Cheesecake Factory(bond)0.4%
Marriott Vacations Worldwide(bond)0.3%
Super Micro Computer(preferred)0.3%
Apollo Global Management(preferred)0.3%
Golar LNG(bond)0.3%
LCI Industries(bond)0.3%
Electronic ArtsEA0.3%
Norfolk SouthernNSC0.3%
Halozyme Therapeutics(bond)0.2%
Chart Industries0.2%
Livanova(bond)0.2%
PPL Cap FDG(bond)0.2%
Bill Holdings(bond)0.2%
Whirlpool(preferred)0.2%
KenvueKVUE0.2%
PenumbraPEN0.1%
RallybioRLYB0.1%
Warner Bros. DiscoveryWBD0.1%
DigitalBridge GroupDBRG0.1%
Nuvalent0.1%
Ares Management(preferred)0.1%
Etsy(bond)0.1%
Dexcom(bond)0.1%
Shift4 Pmts(preferred)0.1%
Apogee Therapeutics0.1%
TopBuildBLD0.1%
TPG Mortgage Investment TrustMITTunder 0.1%
AESAESunder 0.1%
Bio-techneTECHunder 0.1%
Cherry Hill Mortgage InvestmentCHMIunder 0.1%
Travere Therapeutics(bond)under 0.1%
Payoneer GlobalPAYOunder 0.1%
Nuvation Bio(bond)under 0.1%
Falcon’s Beyond GlobalFBYDW(warrant)under 0.1%
Spectral AIMDAIW(warrant)under 0.1%
Kodiak AIKDKRW(warrant)under 0.1%
Alpha Modus HoldingsAMODW(warrant)under 0.1%
Lifezone MetalsLZM/WS(warrant)under 0.1%
Coincheck GroupCNCKW(warrant)under 0.1%
RoadzenRDZNW(warrant)under 0.1%
SunpowerSPWRW(warrant)under 0.1%
Blue GoldBGLWW(warrant)under 0.1%
Baird Medical Investment HoldingsBDMDW(warrant)under 0.1%
Lotus TechnologyLOTWW(warrant)under 0.1%
XBP Global HoldingsXBPEW(warrant)under 0.1%
P3 Health PartnersPIIIW(warrant)under 0.1%

“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.

Portfolio by sector

● Health Care 41%
● Industrials 21%
● No sector 15%
● Financials 10%
● Consumer Discretionary 6%
● Real Estate 3%
● Energy 2%
● Materials 1%

How its portfolio changed (8 quarters)

Positions

Q2 2026: 82

820

Q3 2024Q2 2026

Top 10 weight

Q2 2026: 76%

100%76%

Q3 2024Q2 2026

Traded turnover

Q2 2026: 21.0%

28.9%0

Q3 2024Q2 2026

Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.

Stakes above 5% (13D/13G)

Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.

How we classify it

Not counted as a concentrated manager: it is a private equity or venture firm; its stocks are usually holdings that went public. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided

Managers of a similar size

A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.

Glenview Capital ManagementInvestment firm · $5.0 bn
Kayne Anderson Capital Advisors$5.1 bn
Maple Rock Capital PartnersInvestment firm · $5.1 bn
Akre Capital ManagementInvestment firm · $5.1 bn
Skye Global ManagementInvestment firm · $5.1 bn
MFN Partners ManagementInvestment firm · $4.8 bn

What it reported after the quarter end (Q2 2026)

What changed this quarter

Top holdings

Portfolio by sector

How its portfolio changed (8 quarters)

Stakes above 5% (13D/13G)

Managers of a similar size

Follow TPG Gp A for free